NZR-16655-16049
3 vaccinations
2 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 853 / AZ
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-29
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-07
- 2021-03-12
- 2021-03-19
- 2021-05-09
-
2021-08-13
Survey response — 6 months, dose 2MedDRA: Cough, Nasal congestion, Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: Stuffy nose, sore throat, coughMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Alopecia, Menstruation irregular, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hair loss, skin rashes, and irregular menstrual cyclesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Stuffy nose, sore throat, cough
Release 11 — 12 months, dose 2
Symptoms: Hair loss, skin rashes, and irregular menstrual cycles
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nasal congestion | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release